Dima Biotechnology

DIMA Biotechnology Ltd. is a leading biotech firm specializing in preclinical R&D solutions for the Biopharma industry. We offer 5,000+ pre-designed validated antibody molecules tailored to BioPharma research. Our goal is to develop antibodies for all potential drug targets, accelerating drug discovery for BioPharma. We excel in innovative antibody tech: 1. DiMPro™ Membrane Protein Platform: Express and purify membrane proteins, including GPCRs and ion channels, using mammalian cells. Our inventory includes 1,000+ functional proteins with five distinct solutions. 2. DimAb® Single B Cell Antibody Discovery Platform: Access over 10,000 positive hits in one month through our DimAb® B cell library. 3. DiLibrary™ Mammalian Display Antibody Engineering Platform: Superior antibody engineering for humanization, affinity maturation, and more, outperforming phage or yeast displays. 4. DiAssay™ Antibody Evaluation Platform: Screening processes for Bispecific Antibodies, Antibody-Drug Conjugates, and CAR-T Therapies. Our mission is to empower the BioPharma sector with advanced solutions, fostering innovation and expediting life-changing therapy development.